Nuclear Medicine and Biology

Papers
(The H4-Index of Nuclear Medicine and Biology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Review on 99mTc radiopharmaceuticals with emphasis on new advancements92
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations57
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far55
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion49
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historica47
Production, purification and availability of 211At: Near term steps towards global access46
A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)336
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours34
Gold nanoparticles meet medical radionuclides31
Alpha emitting nuclides for targeted therapy30
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology30
The development of 11C-carbonylation chemistry: A systematic view27
Neutron-activated theranostic radionuclides for nuclear medicine25
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals25
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb22
Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides21
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-1820
The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence20
18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging18
Auger: The future of precision medicine18
0.51578783988953